Ana Ceniceros

Ana holds degrees in Biology and Biochemistry from the University of Navarra and obtained her PhD from the University of Groningen, where she focused on the discovery of novel antibiotics in Streptomyces and Rhodococcus. She conducted postdoctoral research at the University of Oviedo on antitumor compounds derived from Actinobacteria. She later served as a quality control technician at 3P Biopharmaceuticals and currently holds the position of R&D Manager at LEV2050.